These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 21350422)
1. [Neuromidin in mixed vascular and Alzheimer's dementia]. Damulin IV; Stepkina DA; Lokshina AB Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):40-3. PubMed ID: 21350422 [TBL] [Abstract][Full Text] [Related]
2. [Use of reminyl (galantamine) in the treatment of dementia]. Voronkova KV; Pylaeva OA; Mazal'skaia OV; Lemeshko ID; Petrukhin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):26-30. PubMed ID: 16608108 [TBL] [Abstract][Full Text] [Related]
3. [The use of neuromidin in patients with minor ischemic stroke]. Maksimova MIu; Sharov MN; Sineva NA; Vodop'ianov NP Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):35-40. PubMed ID: 22224243 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of neuromidin in alcoholic encephalopathy]. Barantsevich ER; Posokhina OV; Smirnova AIu; Kurashevich KG Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(3):49-53. PubMed ID: 21423115 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273 [TBL] [Abstract][Full Text] [Related]
6. [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia]. Gavrilova SI; Zharikov GA Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):59-65. PubMed ID: 14763262 [No Abstract] [Full Text] [Related]
7. [The treatment of Alzheimer's disease in patients with comorbid somatic pathology]. Selezneva ND; Gavrilova SI; Kalyn IaB; Kolykhalov IV; Fedorova IaB Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):35-42. PubMed ID: 18833116 [TBL] [Abstract][Full Text] [Related]
8. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276 [No Abstract] [Full Text] [Related]
9. [Neuromidin in the treatment of vascular cognitive disorders]. Golovkova MS; Zakharov VV; Lifshits MIu; Iakhno NN Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):20-6. PubMed ID: 18379458 [TBL] [Abstract][Full Text] [Related]
10. Galantamine: a review of its use in Alzheimer's disease and vascular dementia. Corey-Bloom J Int J Clin Pract; 2003 Apr; 57(3):219-23. PubMed ID: 12723727 [TBL] [Abstract][Full Text] [Related]
11. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias. Masterman D Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487 [No Abstract] [Full Text] [Related]
12. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Kertesz A Curr Neurol Neurosci Rep; 2002 Nov; 2(6):503-4. PubMed ID: 12359103 [No Abstract] [Full Text] [Related]
13. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561 [TBL] [Abstract][Full Text] [Related]
14. Galantamine: use in Alzheimer's disease and related disorders. Bullock R Expert Rev Neurother; 2004 Mar; 4(2):153-63. PubMed ID: 15853556 [TBL] [Abstract][Full Text] [Related]
15. [The use of ipidacrinum (neuromidin) in mononeuropathies]. Bel'skaia GN; Popov DV; Gusev VV; Tikhomirova IN; Lukashevich IG; L'vova OA Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):31-2. PubMed ID: 23250595 [No Abstract] [Full Text] [Related]